Market Tracker

09/17 7:18am ET

SPDR® S&P Biotech ETF (XBI)

Data as of Sep 16
 +0.85 / +0.54%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month+1.41% 3 years+35.68%
3 months+4.81% 5 years+23.08%
1 year+23.85% Since inception+14.71%
Data through 09/17/2014

Quote Details

Previous close$156.91
Open day’s range-- – --
Net asset value (NAV)157.70 (09/16/2014)
Daily volume336,922
Average volume (3 months)399,178
Data as of 09/16/2014

Peer Comparisonvs. Health ETFs

Performance 5-yr return+23.08%+24.14%
Expense Gross exp ratio0.35%0.42%
Risk 5 year sharpe ratio1.001.44
Net assets$1.2B$1.5B
Average market cap$2.3B$27.4B
Average P/E--27.7
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
PBYI Puma Biotechnology Inc5.32%
ITMN InterMune Inc2.00%
ANAC Anacor Pharmaceuticals Inc1.72%
EXAS Exact Sciences Corp1.62%
GILD Gilead Sciences Inc1.61%
UTHR United Therapeutics Corp1.59%
PCYC Pharmacyclics Inc1.58%
KERX Keryx Biopharmaceuticals Inc1.55%
VRTX Vertex Pharmaceuticals Inc1.54%
RCPT Receptos Inc1.54%